Hep C Knowledge Bank

Goralczyk AD. et al. (2013) Treatment of chronic HCV genotype 1 infection with telaprevir: a Bayesian mixed treatment comparison of fixed-length and response-guided treatment regimens in treatment-naive and -experienced patients. BMC Gastroenterology, 13:

Dimova RB. et al. (2013) Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clinical Infectious Diseases, 56(6):806-816.

Davies A. et al. (2013) Treatment outcomes of treatment-naive Hepatitis C patients co-infected with HIV: a systematic review and meta-analysis of observational cohorts. PLoS ONE, 8(2):e55373.

Cooper C. et al. (2013) Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis. Qjm, 106(2):153-163.

Chou R. et al. (2013) Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review. Annals of Internal Medicine, 158(2):114-123.

Aspinall EJ. et al. (2013). Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clinical Infectious Diseases, 57(Suppl 2): 80-91.

Cottrell. et. al. (2013). Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the US Preventive Services Task Force. Annals of Internal Medicine, 158(2), 109-113.

Spillane, H. et al. (2012). Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users. Trop Med Int Health, 17(12), 1255-1263.

Lok, AS. et al. (2012). Preliminary study of two antiviral agents for hepatitis C genotype 1. N Engl J Med, 366(3), 216-24.

Forbi, JC. et al. (2012). Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa. J Gen Virol, 93, 1410-21.

Pages